Ruta Brazauskas, PhD

Associate Professor

Locations

Biostatistics

Contact Information

Biography

Education

PhD, Biostatistics, Medical College of Wisconsin, Milwaukee, WI, 2003
MS, Statistics, University of Texas at Dallas, Richardson, TX, 1999
BS, Applied Mathematics, Vilnius University, Lithuania, 1992

Research Interests

Dr. Ruta Brazauskas joined the Division of Biostatistics in June 2008. Dr. Brazauskas’ research interests include survival analysis and competing risks. Most recent methodological work on the issues of paired studies in survival analysis was funded by the CTSA supplemental grant awarded to a group of faculty members at the Division. Her collaborative work is mostly focused on the outcomes of bone marrow transplantation (BMT) and in particular long-tern effects of the BMT. Dr. Brazauskas is the lead statistician of the Late Effects Working Committee and Health Policy Working Committee at the Center for International Bone Marrow Transplant Research. Her other collaborators include MCW physicians from various departments as well as researchers in the area of public health. In 2012, Dr. Brazauskas received the Graduate Student Association's Teacher of the Year Award for her exceptional teaching in Biostatistics.

Curriculum Vitae

Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.

(Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK.) Leuk Res. 2018 Jul 19.
Patient-reported distress is prevalent in systemic light chain (AL) amyloidosis but not determined by severity of disease.

(Wright NL, Flynn KE, Brazauskas R, Hari P, D'Souza A.) Amyloid. 2018 Jun;25(2):129-134.
Female Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell Transplantation.

(Bhatt NS, Brazauskas R, Tecca HR, Vogel J, Mattila D, Lee SJ, Horowitz MM, Rizzo JD, Shaw BE.) J Pediatr Hematol Oncol. 2018 Jun 19.
Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.

(Schneidewend R, Hosking P, Brazauskas R, Peterson J, Beaudin C, Michaelis L, Atallah E, Hari P, Carlson K.) Acta Haematol. 2018;139(3):171-175.
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.

(Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, Flowers MED, Battiwalla M, Beebe K, Dietz AC, Dvorak CC, Giller R, Jacobsohn DA, Kletzel M, Martin PL, Nemecek ER, Nuechterlein B, Talano JA, Pulsipher MA, Baker KS.) Bone Marrow Transplant. 2018 Oct;53(10):1278-1287.
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.

(Wood WA, Brazauskas R, Hu ZH, Abdel-Azim H, Ahmed IA, Aljurf M, Badawy S, Beitinjaneh A, George B, Buchbinder D, Cerny J, Dedeken L, Diaz MA, Freytes CO, Ganguly S, Gergis U, Almaguer DG, Gupta A, Hale G, Hashmi SK, Inamoto Y, Kamble RT, Adekola K, Kindwall-Keller T, Knight J, Kumar L, Kuwatsuka Y, Law J, Lazarus HM, LeMaistre C, Olsson RF, Pulsipher MA, Savani BN, Schultz KR, Saad AA, Seftel M, Seo S, Shea TC, Steinberg A, Sullivan K, Szwajcer D, Wirk B, Yared J, Yong A, Dalal J, Hahn T, Khera N, Bonfim C, Atsuta Y, Saber W.) Biol Blood Marrow Transplant. 2018 Sep;24(9):1928-1935.
Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation.

(D'Souza A, Millard H, Knight J, Brazauskas R, Lee SJ, Flynn KE, Rizzo JD, Shaw BE.) Bone Marrow Transplant. 2018 Aug;53(8):1079-1082.
Presence of fluorescent in situ hybridization abnormalities is associated with plasma cell burden in light chain amyloidosis.

(Hammons L, Brazauskas R, Pasquini M, Hamadani M, Hari P, D'Souza A.) Hematol Oncol Stem Cell Ther. 2018 Jun;11(2):105-111.
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.

(Arnold SD, Brazauskas R, He N, Li Y, Aplenc R, Jin Z, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Majhail NS, Diaz MA, Freytes CO, Wood WA, Savani BN, Kamble RT, Parsons S, Ahmed I, Sullivan K, Beattie S, Dandoy C, Munker R, Marino S, Bitan M, Abdel-Azim H, Aljurf M, Olsson RF, Joshi S, Buchbinder D, Eckrich MJ, Hashmi S, Lazarus H, Marks DI, Steinberg A, Saad A, Gergis U, Krishnamurti L, Abraham A, Rangarajan HG, Walters M, Lipscomb J, Saber W, Satwani P.) Haematologica. 2017 11;102(11):1823-1832.
Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.

(Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, Vogel J, Petroske C, Mattila D, Drexler R, Lee SJ, Horowitz MM, Rizzo JD.) Cancer. 2017 Dec 01;123(23):4687-4700.
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

(Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A.) Blood. 2017 08 31;130(9):1156-1164.
Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation.

(Cheng YC, Shi Y, Zhang MJ, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayash L, Gale RP, Lazarus H, Holmberg L, Lill M, Olsson RF, Wirk BM, Arora M, Hari P, Ueno N.) J Cancer. 2017;8(6):1009-1017.

Ruta Brazauskas, PhD